LIVN
LivaNova·NASDAQ
--
--(--)
--
--(--)
LIVN fundamentals
LivaNova (LIVN) Revenue Breakdown: Q3 2025 Business & Regional Performance
LivaNova (LIVN) reported total revenue of 357.75M USD in Q3 2025, with its core business segment Cardiac Surgery contributing 56.80%. Regionally, United States remained the largest market, accounting for 53.23% of total revenue. Explore LivaNova's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
LivaNova (LIVN) reported total revenue of 357.75M USD in Q3 2025, with its core business segment Cardiac Surgery contributing 56.80%. Regionally, United States remained the largest market, accounting for 53.23% of total revenue. Explore LivaNova's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is LivaNova's latest dividend and current dividend yield?Did LivaNova beat or miss consensus estimates last quarter?What factors drove the changes in LivaNova's revenue and profit?What is LivaNova's gross profit margin?What guidance did LivaNova's management provide for the next earnings period?What is the revenue and EPS growth rate for LivaNova year over year?What were the key takeaways from LivaNova's earnings call?What is the market's earnings forecast for LivaNova next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
